nct02637284 bpc-157 A human trial was registered. The results were submitted. Then they disappeared from public view. In 2015, a Phase I, randomized, placebo-controlled clinical trial (NCT02637284) was launched to evaluate an oral BPC-157 (5mg) – Ascension Peptides
Pay in 4 interest-free payments of $5.94 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25




:max_bytes(150000):strip_icc():focal(644x399:646x401)/Ozempic-injection-101822-f89ffa28671841cdb26ddb53f2b48803.jpg)




)







)

:max_bytes(150000):strip_icc()/VWH_NEWS_GLP1_TastePerception-579dc0e01a604949af26d0e23e75b7fc.png)







